BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 8704183)

  • 1. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: relationship to cyclin D1.
    Zukerberg LR; Benedict WF; Arnold A; Dyson N; Harlow E; Harris NL
    Blood; 1996 Jul; 88(1):268-76. PubMed ID: 8704183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry.
    Zukerberg LR; Yang WI; Arnold A; Harris NL
    Am J Clin Pathol; 1995 Jun; 103(6):756-60. PubMed ID: 7540362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.
    Jares P; Campo E; Pinyol M; Bosch F; Miquel R; Fernandez PL; Sanchez-Beato M; Soler F; Perez-Losada A; Nayach I; Mallofré C; Piris MA; Montserrat E; Cardesa A
    Am J Pathol; 1996 May; 148(5):1591-600. PubMed ID: 8623927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclin D1 protein in centrocytic/mantle cell lymphomas with and without rearrangement of the BCL1/cyclin D1 gene.
    Swerdlow SH; Yang WI; Zukerberg LR; Harris NL; Arnold A; Williams ME
    Hum Pathol; 1995 Sep; 26(9):999-1004. PubMed ID: 7545645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 immunohistochemical staining is useful in distinguishing mantle cell lymphoma from other low-grade B-cell neoplasms in bone marrow.
    Vasef MA; Medeiros LJ; Koo C; McCourty A; Brynes RK
    Am J Clin Pathol; 1997 Sep; 108(3):302-7. PubMed ID: 9291459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.
    Nakamura S; Seto M; Banno S; Suzuki S; Koshikawa T; Kitoh K; Kagami Y; Ogura M; Yatabe Y; Kojima M
    Jpn J Cancer Res; 1994 Dec; 85(12):1270-9. PubMed ID: 7531681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.
    Yang WI; Zukerberg LR; Motokura T; Arnold A; Harris NL
    Am J Pathol; 1994 Jul; 145(1):86-96. PubMed ID: 7518196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519).
    Jadayel DM; Lukas J; Nacheva E; Bartkova J; Stranks G; De Schouwer PJ; Lens D; Bartek J; Dyer MJ; Kruger AR; Catovsky D
    Leukemia; 1997 Jan; 11(1):64-72. PubMed ID: 9001420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
    Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
    Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity.
    Ott MM; Bartkova J; Bartek J; Dürr A; Fischer L; Ott G; Müller-Hermelink HK; Kreipe H
    Blood; 1997 Oct; 90(8):3154-9. PubMed ID: 9376597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical interaction of the retinoblastoma protein with human D cyclins.
    Dowdy SF; Hinds PW; Louie K; Reed SI; Arnold A; Weinberg RA
    Cell; 1993 May; 73(3):499-511. PubMed ID: 8490963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1 protein expression in mantle cell lymphoma.
    Alkan S; Schnitzer B; Thompson JL; Moscinski LC; Ross CW
    Ann Oncol; 1995 Jul; 6(6):567-70. PubMed ID: 8573535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation.
    Connell-Crowley L; Harper JW; Goodrich DW
    Mol Biol Cell; 1997 Feb; 8(2):287-301. PubMed ID: 9190208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
    Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.
    Lukas J; Bartkova J; Rohde M; Strauss M; Bartek J
    Mol Cell Biol; 1995 May; 15(5):2600-11. PubMed ID: 7739541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferation-dependent expression and phosphorylation of pRB in B cell non-Hodgkin's lymphomas: dependence on RB1 copy number.
    Galteland E; Smedshammer L; Suo Z; DeAngelis P; Stokke T
    Leukemia; 2002 Aug; 16(8):1549-55. PubMed ID: 12145697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue.
    Wołowiec D; Benchaib M; Pernas P; Deviller P; Souchier C; Rimokh R; Felman P; Bryon PA; Ffrench M
    Leukemia; 1995 Aug; 9(8):1382-8. PubMed ID: 7643628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappa B-dependent induction of cyclin D1 by retinoblastoma protein (pRB) family proteins and tumor-derived pRB mutants.
    Takebayashi T; Higashi H; Sudo H; Ozawa H; Suzuki E; Shirado O; Katoh H; Hatakeyama M
    J Biol Chem; 2003 Apr; 278(17):14897-905. PubMed ID: 12594215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of P19 EC cells leads to differential modulation of cyclin-dependent kinase activities and to changes in the cell cycle profile.
    Kranenburg O; de Groot RP; Van der Eb AJ; Zantema A
    Oncogene; 1995 Jan; 10(1):87-95. PubMed ID: 7824282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.